ISLB 2023


Call for Abstracts

Organized By

Stay up to Date

Call For Abstracts Closed

Abstract submission for ISLB 2023 is now closed. Thank you all for your participation. Abstract notification will be sent on August 17, 2023.

Important Dates

4 May 2023

Abstract Submission Opens

28 July 2023

Abstracts Submission Deadline (Extended)

17 August 2023

Abstract Notifications

31 August 2023

Presentation Acceptance Deadline

8 September 2023

Early Registration Deadline

19 – 21 November 2023

Congress Dates

Abstract Submission Guidelines

Authors are asked to present their work with precise and clear objectives, directly related to their evidence and scientific support to support their research or clinical study. The Executive Committee and the Scientific Board of the Congress will evaluate each abstract presented.

  • Abstracts are accepted in English only
  • The maximum word limit for Abstract title is 20 (excluding spaces)
  • The maximum word limit for Abstract text is 300 + 1 image or table (excluding spaces) or 350 with no images or tables (excluding spaces)
  • 1 image or table is equal to 50 words
  • Abstracts submitted via email or paper are not accepted
  • There can be only 1 Presenting Author
  • The maximum number of Co-authors is 10
  • There is no limit to the number of abstracts submitted by an Author
  • Required sections for Abstract submission: Introduction, Methods, Results, Conclusion
  • Submitting an abstract does not register you for ISLB2023
  • If your abstract is accepted as Oral Presentation or Poster you will be entitled to a discounted rate (rates to be disclosed in Mid May)
  • Liquid Biopsy in Early Cancer Detection
  • Clinical Trials Including Liquid Biopsies
  • Composite Biomarkers Using Liquid Biopsy
  • Clinical Applications of Liquid Biopsy
  • Liquid Biopsy Beyond ctDNA
  • Advocacy & Regulatory​ Aspects of Liquid Biopsy
  • Miscellaneous
  • Authors must agree to allow publication of accepted abstract(s) on the conference website.
  • All authors must complete a conflict of interest during their abstract submission (no form necessary)
  • If your research has been granted any commercial or institutional support, you will be asked to disclose this during the submission process
  • Grants must be disclosed

The Executive Committee and Scientific Board will be reviewing each abstract and selecting Poster and Oral Presentations.

  • Prizes are awarded to the highest scoring abstract
  • No extra steps are necessary to apply to the Award

Frequently Asked Questions

Are case reports considered for abstracts?
No, we do not allow the submission of case reports.

Does ISLB accept abstracts that have been submitted and presented to a previous Conference (ie, encore abstracts, trials in progress encore abstracts)?
An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the presentation. Submitters are required to list any previous presentations in the introduction section of the abstract.

When will I receive the Notification Letter?
Notification Letters will be sent in early August

Where will my abstract be published?
Accepted abstracts will be published on The Journal of Liquid Biopsy.

I am having trouble submitting my abstract – what can I do?
Please see here a Step by Step Guide. If after reading this, you still have questions or troubles, please email at [email protected].